Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06829914 · ClinicalTrials.gov registry record · NA
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
A NA study of Common Femoral Artery Stenosis and Calcification; Heart, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06829914 is a NA study of Common Femoral Artery Stenosis and Calcification; Heart that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06829914, a NA study of Common Femoral Artery Stenosis and Calcification; Heart, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that Shockwave with DCB is non-inferior to surgical endarterectomy for common femoral artery (CFA) stenosis with regard to primary efficacy and safety endpoints. The study will challenge the current guideline that recommends common femoral endarterectomy (CFE) as the primary treatment for symptomatic CFA stenosis.
Conditions Studied
Interventions
- DEVICE Shockwave Catheter
- PROCEDURE CFA Endarterectomy
Study Locations (1)
Texas
- Baylor Scott & White The Heart Hospital - Plano - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06829914
The ClinicalTrials.gov registry entry for NCT06829914 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Common Femoral Artery Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Shockwave Catheter is the first listed.
NCT06829914 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06829914 about?
NCT06829914 is a clinical study titled "Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes". The investigators hypothesize that Shockwave with DCB is non-inferior to surgical endarterectomy for common femoral artery (CFA) stenosis with regard to primary efficacy and safety endpoints. The study will challenge the current guideline that recommends common femoral endarterectomy (CFE) as the pr...
What is the current status of trial NCT06829914?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-03-07. Estimated completion is 2026-03-30.
What conditions does trial NCT06829914 study?
This clinical trial studies the following conditions: Common Femoral Artery Stenosis, Calcification; Heart.
What interventions are being tested in trial NCT06829914?
The interventions under investigation include: Shockwave Catheter (DEVICE), CFA Endarterectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06829914?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06829914 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.